Sep. 15, 2009 (Business Wire) -- UBS (NYSE:UBS):
WHAT: UBS’s Eleventh Annual Global Life Sciences Conference, one of the industry’s largest, will feature presentations from executives of more than 250 companies over three days. Presenting companies include:
| | | | | | | | | |
| Actelion Pharmaceuticals Ltd. | | | | DENTSPLY International | | | | Pall Corporation |
| Agilent Technologies, Inc. | | | | Eli Lilly and Company | | | | PharMerica Corporation |
| Alcon, Inc. | | | | F. Hoffmann - La Roche Ltd. | | | | QIAGEN N.V. |
| Alexion Pharmaceuticals, Inc. | | | | Genzyme Corporation | | | | Quality Systems, Inc. |
| Allergan, Inc. | | | | Gilead Sciences, Inc. | | | | ResMed Inc. |
| Allscripts-Misys Healthcare Solutions, Inc. | | | | Hospira, Inc. | | | | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| AstraZeneca PLC | | | | Human Genome Sciences Inc. | | | | Sigma-Aldrich Corporation |
| Biogen Idec Inc. | | | | Illumina, Inc. | | | | Smith & Nephew plc |
| BioMed Realty Trust Inc. | | | | IMS Health, Inc. | | | | Stericycle, Inc. |
| bioMerieux SA | | | | Intuitive Surgical, Inc. | | | | Stryker Corporation |
| Cardinal Health, Inc. | | | | Laboratory Corporation of America Holdings | | | | Teva Pharmaceutical Industries Limited |
| CareFusion Corporation | | | | Life Technologies Corporation | | | | Thermo Fisher Scientific Inc. |
| Celgene Corporation | | | | Merck & Co., Inc. | | | | Vertex Pharmaceuticals Incorporated |
| Cephalon Corporation | | | | Mettler-Toledo International Inc. | | | | Zimmer Holdings, Inc. |
| Charles River Laboratories International, Inc. | | | | Millipore Corporation | | | | |
| Covance Inc. | | | | Mylan Inc. | | | | |
| Danaher Corporation | | | | Myriad Genetics, Inc. | | | | |
| | | | | Novartis AG | | | | |
*This is a partial list of presenting companies. Companies subject to change. To access the agenda, please go to www.ibb.ubs.com/Conferences.
WHY: The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide insight on the biotechnology, life sciences, medical technology and pharmaceutical fields to over 2,000 attendees.
AUDIO WEBCAST: Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.
WHEN: Monday, September 21 through Wednesday, September 23, 2009
WHERE: The Grand Hyatt at 42nd Street in Grand Central Terminal, New York City
REGISTER: Members of the media may register for the conference by contacting Doug Morris at douglas.o-morris@ubs.com or (212) 882-5694.
Members of the general public may register by contacting Denise Kwiatkowski at denise.kwiatkowski@ubs.com.
